glp-1 and psoriasis receptor agonists: emerging therapeutic potential in management โ current evidence future outlook | European Journal of Clinical Pharmacology The Dermatologist | ๐ฅ GLP-1s
Description
The question isnt whether theres patient demandthere absolutely is
It's a signaling problem which is exactly what a signaling medication can address
doi: 10.1056/NEJMc2109509
The answer lies in how these medications affect digestion and the risks they pose under anesthesia
Their simplicity is what makes them effective as a small meal
The medication is compounded by licensed 503A pharmacies, available in all 50 states, and eligible for HSA/FSA accounts without requiring insurance or membership fees
